Eflornithine for treating high-risk neuroblastoma with complete or partial response after immunotherapy [ID4060]

  • In development
  • GID-TA10990
  • Expected publication date: TBC

Documents

Documents created during the development process.

Declaration of interests

Invitation to participate

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators